Verrucous hemangioma expresses primitive markers

Journal of Cutaneous Pathology

Volumn 40, Issue 4, 2013, Pages 391-396

  Laing, Emma L ^a   Brasch, Helen D ^a,b   Steel, Ryan ^a   Jia, Jun ^a   Itinteang, Tinte ^a   Tan, Swee T ^a,b,c   Day, Darren J ^d  

^a GILLIES MCINDOE RESEARCH INSTITUTE   (New Zealand)

^b HUTT HOSPITAL   (New Zealand)

^c UNIVERSITY OF OTAGO   (New Zealand)

^d VICTORIA UNIVERSITY OF WELLINGTON   (New Zealand)

Author keywords

brachyury; hemoglobin chain; stem cells; verrucous hemangioma

Indexed keywords

GLUCOSE TRANSPORTER 1; HEMOGLOBIN VARIANT; TUMOR MARKER;

ADULT; AGED; ARTICLE; HEMANGIOMA; HUMAN; MALE; METABOLISM; PATHOLOGY; SKIN TUMOR; VASCULAR ENDOTHELIUM;

ADULT; AGED; ENDOTHELIUM, VASCULAR; GLUCOSE TRANSPORTER TYPE 1; HEMANGIOMA; HEMOGLOBINS, ABNORMAL; HUMANS; MALE; SKIN NEOPLASMS; TUMOR MARKERS, BIOLOGICAL;

EID: 84875236889     PISSN: 03036987     EISSN: 16000560     Source Type: Journal    
DOI: 10.1111/cup.12078     Document Type: Article

References (18)

1. Enjolras O, Mulliken JB,. Vascular tumors and vascular malformations (new issues). Adv Dermatol 1997; 13: 375.
2. Mulliken JB, Glowacki J,. Hemangiomas and vascular malformations in infants and children: a classification based on endothelial characteristics. Plast Reconstr Surg 1982; 69: 412.
3. Tennant L, Mulliken J, Perez-Atayde A, Kozakewich H,. Verrucous hemangioma revisited. Pediatr Dermatol 2006; 23: 208.
4. Imperial R, Helwig E,. Verrucous hemangioma. A clinicopathological study of 21 cases. Arch Dermatol 1967; 96: 247.
5. Clairwood M, Bruckner A, Dadras S,. Verrucous hemangioma: a report of two cases and review of the literature. J Cutan Pathol 2011; 38: 740.
6. North P, Waner M, Mizeracki A, et al. GLUT1: a newly discovered immunohistochemical marker for juvenile hemangiomas. Hum Pathol 2000; 31: 11.
7. Cheong S, Lim J, Kim S, et al. A case of eccrine angiomatous hamartoma associated with verrucous hemangioma. Ann Dermatol 2009; 21: 304.
8. Lawley LP, Cerimele F, Weiss SW, et al. Expression of Wilms tumor 1 gene distinguishes vascular malformations from proliferative endothelial lesions. Arch Dermatol 2005; 141: 1297.
9. Itinteang T, Brasch H, Tan ST, Day DJ,. Expression of components of the renin-angiotensin system in proliferating infantile haemangioma may account for the propranolol-induced accelerated involution. J Plast Reconstr Aesthet Surg 2011; 64: 759.
10. Itinteang T, Tan ST, Brasch H, Day DJ,. Haemogenic endothelium in infantile haemangioma. J Clin Pathol 2010; 63: 982.
11. Itinteang T, Tan ST, Brasch H, Day DJ,. Primitive mesodermal cells with a neural crest stem cell phenotype predominate proliferating infantile haemangioma. J Clin Pathol 2010; 63: 771.
12. Itinteang T, Vishvanath A, Day DJ, Tan ST,. Mesenchymal stem cells in infantile haemangioma. J Clin Pathol 2011; 64: 232.
13. Itinteang T, Tan ST, Brasch H, Vishvanath A, Day DJ,. Primitive erythropoiesis in infantile haemangioma. Br J Dermatol 2011; 164: 1097.
14. Itinteang T, Tan ST, Guthrie S, et al. A placental chorionic villous mesenchymal core cellular origin for infantile haemangioma. J Clin Pathol 2011; 64: 870.
15. Kahn H, Bailey D, Marks A,. Monoclonal antibody D2-40, a new marker of lymphatic endothelium, reacts with Kaposi's sarcoma and a subset of angiosarcomas. Mod Pathol 2002; 15: 434.
16. Calonje E, Brenn T, Lazar A, McKee P,. McKee's pathology of the skin, 4 ed. Elsevier, Oxford, 2011; P1711.
17. Al Dhaybi R, Powell J, McCuaig C, Kokta V,. Differentiation of vascular tumors from vascular malformations by expression of Wilms tumor 1 gene: evaluation of 126 cases. J Am Acad Dermatol 2010; 63: 1052.
18. Peschle C, Mavilio F, Carè A, et al. Haemoglobin switching in human embryos: asynchrony of ζ→α and Ïμ→γ- globin switches in primitive and definitive erythropoietic lineage. Nature 1985; 313: 235.